Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ) Stock
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications. It also offers Xiaojin pills, Tian Ranshexiang Xiaojin pills, Xiaokechuan capsules, Jiuwei Qianghuo granules, Xiongdan powder, Bear Bile powder, and Wenweishu tablets to treat glandular hyperplasia, inflammatory diseases, bone trauma and soft tissue injury, and other related diseases. In addition, the company provides bacillus cereus live bacteria capsules, bacillus cereus live bacteria tablets are therapeutic live bacteria microecological preparations to treat enteritis, diarrhea, infantile diarrhea, and intestinal dysfunction. The company was founded in 1990 and is headquartered in Tonghua, China.
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd is led by CEO Yufu Zhang, employs 1,480 people, headquartered in Tonghua, CN, publicly traded since 1997.
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ) stock trades at $15.03 with a market capitalization of $14.53B. The stock is valued at a price-to-earnings (P/E) ratio of 501.00, price-to-book of 6.27, price-to-sales of 13.49. Over the past 52 weeks the stock has ranged between $13.95 and $30.20, and currently trades 50.2% below its 52-week high.
On profitability, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd generates a return on equity (ROE) of 1.06%, an operating margin of 7.99%, a net profit margin of 2.28%.
Official website: www.thjm.cn
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ) — frequently asked questions
What is Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ) stock price today?
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ) is currently trading at $15.03, down 2.08% today.
What is 000766.SZ P/E ratio?
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's P/E ratio is 501.00. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 000766.SZ return on equity (ROE)?
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's return on equity (ROE) is 1.06%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's market cap?
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd has a market capitalization of $14.53B.
Does 000766.SZ pay a dividend?
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 000766.SZ carry?
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd has a debt-to-equity ratio of 0.87. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 000766.SZ's profit margin?
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd reports a net profit margin of 2.28% — the share of revenue left after every cost, including tax and interest.
What sector is 000766.SZ in?
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd is classified under Healthcare, in the Drug Manufacturers - Specialty & Generic industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 000766.SZ listed on?
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd trades on SHZ under the ticker 000766.SZ.
What is 000766.SZ's 52-week range?
Over the last year Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd has traded between $13.95 and $30.20.
Related Healthcare Stocks
Popular Stocks
Screens 000766.SZ currently matches
On the figures above, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd passes the filters for 6 of our ready-made screens, among them Large Cap Stocks, High PE Stocks, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.